Reduction of Cardiovascular Disease and Mortality Versus Risk of New-Onset Diabetes Mellitus With Statin Use in Patients With Rheumatoid Arthritis.
Gulsen OzenSophie Dell'AnielloSofia PedroKaleb D MichaudSamy SuissaPublished in: Arthritis care & research (2022)
Statins are associated with important reductions in CVD and mortality that outweigh the modest increase in type 2 DM risk in RA patients.
Keyphrases
- cardiovascular disease
- cardiovascular events
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- type diabetes
- coronary artery disease
- rheumatoid arthritis
- prognostic factors
- disease activity
- cardiovascular risk factors
- systemic lupus erythematosus
- metabolic syndrome
- ankylosing spondylitis
- systemic sclerosis
- idiopathic pulmonary fibrosis